A detailed history of Charter Oak Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Charter Oak Capital Management, LLC holds 8,228 shares of ABBV stock, worth $1.37 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
8,228
Previous 7,871 4.54%
Holding current value
$1.37 Million
Previous $1.22 Million 22.89%
% of portfolio
0.16%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $57,055 - $65,009
357 Added 4.54%
8,228 $1.5 Million
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $48,985 - $55,169
356 Added 4.74%
7,871 $1.22 Million
Q3 2023

Oct 04, 2023

SELL
$133.59 - $154.65 $1,202 - $1,391
-9 Reduced 0.12%
7,515 $1.12 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $1,590 - $1,978
12 Added 0.16%
7,524 $1.01 Million
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $1,156 - $1,332
8 Added 0.11%
7,512 $1.2 Million
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $1,521 - $1,824
11 Added 0.15%
7,504 $0
Q3 2022

Dec 06, 2022

BUY
$134.21 - $153.93 $21,876 - $25,090
163 Added 2.22%
7,493 $1.01 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $5,229 - $6,648
-38 Reduced 0.52%
7,330 $1.12 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $110,995 - $137,713
841 Added 12.88%
7,368 $1.19 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $7,842 - $9,922
73 Added 1.13%
6,527 $884,000
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $3,404 - $3,864
32 Added 0.5%
6,454 $696,000
Q2 2021

Jul 29, 2021

BUY
$105.21 - $117.21 $20,831 - $23,207
198 Added 3.18%
6,422 $723,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $9,923 - $10,924
97 Added 1.58%
6,224 $674,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $493,162 - $665,821
6,127 New
6,127 $657,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Charter Oak Capital Management, LLC Portfolio

Follow Charter Oak Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Charter Oak Capital Management, LLC with notifications on news.